Daiwa Securities Group
AURA icon

Daiwa Securities Group’s Aura Biosciences AURA Stock Holding History

Daiwa Securities Group’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-165
Closed -$1K – 1211
2025
Q4 		$1K Hold
165
– – ﹤0.01% 1338
2025
Q3 		$1K Hold
165
– – ﹤0.01% 1299
2025
Q2 		$1K Hold
165
– – ﹤0.01% 1248
2025
Q1 		$1K Hold
165
– – ﹤0.01% 1214
2024
Q4 		$1K Buy
+165
New +$1.55K ﹤0.01% 1246

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Daiwa Securities Group's AURA Position: Q1 2026 in Review

Daiwa Securities Group sold out of Aura Biosciences (AURA) in Q1 2026, closing a stake of 165 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in AURA in Q4 2024 and held it in 5 quarters. The position peaked at $1K in Q4 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Daiwa Securities Group reported no remaining Aura Biosciences position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 165 Aura Biosciences shares in Q1 2026, an estimated $1K.
  • Daiwa Securities Group first reported a position in Aura Biosciences in Q4 2024 and held it in 5 quarters.
  • Daiwa Securities Group's Aura Biosciences position peaked at $1K in Q4 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.